Open Journal of Rheumatology and Autoimmune Diseases
Vol.5 No.3(2015), Paper ID 58894, 13
pages
DOI:10.4236/ojra.2015.53012
Predictive Models of Clinical Improvement in Rituximab-Treated Myositis Patients Using Clinical Features, Autoantibodies, and Biomarkers
Jeannette M. Olazagasti, Cynthia S. Crowson, Molly S. Hein, Consuelo Lopez de Padilla, Rohit Aggarwal, Chester V. Oddis, Ann M. Reed
Division of Rheumatology, Mayo Clinic, Rochester, MN, USA
Division of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Division of Rheumatology, Mayo Clinic, Rochester, MN, USA
Division of Rheumatology, Mayo Clinic, Rochester, MN, USA
Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, USA
Division of Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
Division of Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
Copyright © 2015 Jeannette M. Olazagasti, Cynthia S. Crowson, Molly S. Hein, Consuelo Lopez de Padilla, Rohit Aggarwal, Chester V. Oddis, Ann M. Reed et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Olazagasti, J. , Crowson, C. , Hein, M. , de Padilla, C. , Aggarwal, R. , Oddis, C. and Reed, A. (2015) Predictive Models of Clinical Improvement in Rituximab-Treated Myositis Patients Using Clinical Features, Autoantibodies, and Biomarkers.
Open Journal of Rheumatology and Autoimmune Diseases,
5, 68-80. doi:
10.4236/ojra.2015.53012.